Shares of Agios Pharmaceuticals (AGIO) have gained 3.2% over the past four weeks to close the last trading session at 32.69,buttherecouldstillbeasolidupsideleftinthestockifshort−termpricetargetsofWallStreetanalystsareanyindication.Goingbythepricetargets,themeanestimateof41.33 indicates a potential upside of 26.4%.The mean estimate comprises six short-term price targets with a standard deviation of 8.12.Whilethelowestestimateof30 indicates an 8.2% decline from the c ...